LYTIR

Insider · SEC Form 4 · Director

Gary W. Pace

Filed with the SEC as PACE GARY W; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $1.0M of CRDF. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $1.0M in total; Insider sales: $0 in total.Jun: Insider purchases $37KJul: Insider purchases $1.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $1.0MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. CRDFBought: Cardiff Oncology, Inc. Jul 14, 2026 687,285 shares filed Jul 16, 2026 2,043,661 shares held directly after, as filed filing $1.0M
  2. CRDFBought: Cardiff Oncology, Inc. Jun 18, 2026 30,000 shares filed Jun 22, 2026 1,356,376 shares held directly after, as filed filing $37K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.